Jr. Robert E. Funck - 28 Feb 2022 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
EXECUTIVE VICE PRESIDENT
Signature
/s/ Robert E. Funck, Jr. by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
28 Feb 2022
Net transactions value
-$1,315,908
Form type
4
Filing time
02 Mar 2022, 18:44:35 UTC
Previous filing
23 Feb 2022
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Tax liability $1,315,908 -10,750 -4.9% $122.41 206,582 28 Feb 2022 Direct
holding ABT Common shares without par value 10,000 28 Feb 2022 By Trust F1
holding ABT Common shares without par value 10,000 28 Feb 2022 By Trust F1
holding ABT Common shares without par value 18,085 28 Feb 2022 Profit Sharing Trust F2
holding ABT Common shares without par value 500 28 Feb 2022 By Daughter F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust.
F2 Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2022.
F3 The reporting person disclaims beneficial ownership of all securities held by his daughter.